9-136433147-G-GCGCCCACCCCTCTAGCCA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_019892.6(INPP5E):c.1159+7_1159+8insTGGCTAGAGGGGTGGGCG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.001 in 1,600,660 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 6 hom., cov: 28)
Exomes 𝑓: 0.00058 ( 2 hom. )
Consequence
INPP5E
NM_019892.6 splice_region, intron
NM_019892.6 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.695
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 9-136433147-G-GCGCCCACCCCTCTAGCCA is Benign according to our data. Variant chr9-136433147-G-GCGCCCACCCCTCTAGCCA is described in ClinVar as [Benign]. Clinvar id is 695325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00507 (753/148454) while in subpopulation AFR AF = 0.0183 (714/38956). AF 95% confidence interval is 0.0172. There are 6 homozygotes in GnomAd4. There are 337 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712.4 | c.1159+7_1159+8insTGGCTAGAGGGGTGGGCG | splice_region_variant, intron_variant | Intron 4 of 9 | 1 | NM_019892.6 | ENSP00000360777.3 | |||
INPP5E | ENST00000676019.1 | c.1057+7_1057+8insTGGCTAGAGGGGTGGGCG | splice_region_variant, intron_variant | Intron 4 of 9 | ENSP00000501984.1 |
Frequencies
GnomAD3 genomes AF: 0.00505 AC: 749AN: 148340Hom.: 6 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
749
AN:
148340
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000585 AC: 849AN: 1452206Hom.: 2 Cov.: 53 AF XY: 0.000516 AC XY: 373AN XY: 722666 show subpopulations
GnomAD4 exome
AF:
AC:
849
AN:
1452206
Hom.:
Cov.:
53
AF XY:
AC XY:
373
AN XY:
722666
Gnomad4 AFR exome
AF:
AC:
605
AN:
33390
Gnomad4 AMR exome
AF:
AC:
72
AN:
44508
Gnomad4 ASJ exome
AF:
AC:
14
AN:
26078
Gnomad4 EAS exome
AF:
AC:
0
AN:
39662
Gnomad4 SAS exome
AF:
AC:
2
AN:
86154
Gnomad4 FIN exome
AF:
AC:
0
AN:
46438
Gnomad4 NFE exome
AF:
AC:
74
AN:
1110024
Gnomad4 Remaining exome
AF:
AC:
76
AN:
60192
Heterozygous variant carriers
0
46
91
137
182
228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00507 AC: 753AN: 148454Hom.: 6 Cov.: 28 AF XY: 0.00465 AC XY: 337AN XY: 72510 show subpopulations
GnomAD4 genome
AF:
AC:
753
AN:
148454
Hom.:
Cov.:
28
AF XY:
AC XY:
337
AN XY:
72510
Gnomad4 AFR
AF:
AC:
0.0183284
AN:
0.0183284
Gnomad4 AMR
AF:
AC:
0.00180481
AN:
0.00180481
Gnomad4 ASJ
AF:
AC:
0.000289352
AN:
0.000289352
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000209118
AN:
0.000209118
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000888494
AN:
0.0000888494
Gnomad4 OTH
AF:
AC:
0.00194742
AN:
0.00194742
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
May 17, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Joubert syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at